Artificial, with its innovative technology, enables labs to accelerate discoveries and development. Their goal is to empower every lab to realize the benefits of automation. Artificial can, in fact, be considered a digital revolution by bringing robotics, automation, data, and people together on a single easy-to-use platform.
Extending automation into life sciences is even more crucial today, because of the pandemic. It has become clear that we need to take a scalable and reproducible approach to running the research labs.
With Yvonne and Nikhita, I discussed how they combined life sciences and technology at Artificial, as well as how they built an agile and flexible organization as they continued to serve their customers during the pandemic.
Hope you enjoy our interview.
You can watch the video below:
Woodside Capital Partners is the leading corporate finance advisory firm for tech companies in M&A and financings in the $30M-$500M segment. The firm has worked with the best entrepreneurs and investors since 2001, providing ultra-personalized service to select clients. Our team has global vision and reach, and has completed hundreds of successful engagements. We have deep industry knowledge and extensive domain experience in the following sectors: Autonomous Vehicles and ADAS, Computer Vision, Artificial Intelligence, Cloud/Enterprise Software, Cybersecurity, Digital Entertainment & Lifestyle, Health Tech, Internet of Things, Marketing Technology, Networking / Infrastructure, and Robotics. Woodside Capital Partners is a specialist in cross-border transactions, with extensive relationships among venture capitalists, private equity investors, and corporate executives from global 1000 companies. More about Woodside Capital Partners here.
Questions? Contact Katie Elizabeth, Head of Marketing, Woodside Capital Partners at firstname.lastname@example.org